BRAF
7 drugs Oncology
4
approved indications
7
Approved Drugs
6
Companies
16
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (16 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Bayer 2 drugs
Novartis 1 drug
Viatris 1 drug
By Therapeutic Area
Other 4 drugs
Oncology 3 drugs
By Therapeutic Area
Other 4 drugs
STIVARGA, NEXAVAR, QINLOCK, OJEMDA
Oncology 3 drugs
TAFINLAR, SORAFENIB TOSYLATE, ZELBORAF
Indications Treated
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid CarcinomaGastrointestinal Stromal TumorLow-Grade GliomaMetastatic colorectal cancerLocally advanced, unresectable or metastatic gastrointestinal stromal tumorHepatocellular carcinomaMelanomaNon-Small Cell Lung CancerAnaplastic Thyroid CancerSolid TumorsErdheim-Chester DiseaseUnresectable hepatocellular carcinomaAdvanced renal cell carcinomaLocally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment